CORTROSYN Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Cortrosyn, and when can generic versions of Cortrosyn launch?
Cortrosyn is a drug marketed by Amphastar Pharms Inc and is included in one NDA.
The generic ingredient in CORTROSYN is cosyntropin. There are two drug master file entries for this compound. Five suppliers are listed for this compound. Additional details are available on the cosyntropin profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Cortrosyn
A generic version of CORTROSYN was approved as cosyntropin by SANDOZ on June 29th, 2012.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for CORTROSYN?
- What are the global sales for CORTROSYN?
- What is Average Wholesale Price for CORTROSYN?
Summary for CORTROSYN
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Finished Product Suppliers / Packagers: | 3 |
| Raw Ingredient (Bulk) Api Vendors: | 51 |
| Clinical Trials: | 7 |
| Patent Applications: | 1,355 |
| Drug Prices: | Drug price information for CORTROSYN |
| What excipients (inactive ingredients) are in CORTROSYN? | CORTROSYN excipients list |
| DailyMed Link: | CORTROSYN at DailyMed |
Recent Clinical Trials for CORTROSYN
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Vanderbilt University | N/A |
| National Institutes of Health (NIH) | N/A |
| National Heart, Lung, and Blood Institute (NHLBI) | N/A |
Pharmacology for CORTROSYN
| Drug Class | Adrenocorticotropic Hormone |
US Patents and Regulatory Information for CORTROSYN
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Amphastar Pharms Inc | CORTROSYN | cosyntropin | INJECTABLE;INJECTION | 016750-001 | Approved Prior to Jan 1, 1982 | AP | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
